Lutroo Imaging Launches First-in-Human Study of Radiocaine™, a Potential Breakthrough in Pain Imaging
Lutroo Imaging has officially launched a Phase 1 clinical trial of Radiocaine™, a first-of-its-kind PET radiotracer designed to make pain…
Lutroo Imaging has officially launched a Phase 1 clinical trial of Radiocaine™, a first-of-its-kind PET radiotracer designed to make pain…
The opioid crisis has compelled stakeholders in the healthcare industry to seek safer alternatives for pain management. Two examples are…
The economic burden of chronic pain has surpassed $1 trillion annually in the United States, driven by increasing healthcare costs…